Cargando…
CD19 CAR-T细胞治疗复发难治Ph(+)急性B淋巴细胞白血病14例疗效及安全性
OBJECTIVE: This study aimed to examine the safety and efficacy of CD19 chimeric antigen receptor T cell (CD19 CAR-T) therapy in relapsed/refractory Philadelphia chromosome-positive acute B-precursor lymphoblastic leukemia (R/R Ph(+) B-ALL). METHODS: The clinical data of 14 patients with R/R Ph(+) B-...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378286/ https://www.ncbi.nlm.nih.gov/pubmed/32654463 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.06.010 |